Monday, June 15, 2026

North Korea’s New Housing Project: 2,500 Units for Fallen Soldiers’ Families in Pyongyang

North Korea builds a 2,500-unit housing complex for families of troops deployed to Russia, amid concerns of underreported military casualties.

Daewoong Pharmaceutical Gains Mexico Approval for Type 2 Diabetes Drug as Latin America Expansion Accelerates

Daewoong Pharmaceutical's type 2 diabetes drug Enblo has received approval in Mexico, a key market in Latin America.

South Korea Launches $36 Million Medical AI Testbed Program for Real-World Clinical Trials

South Korea launches a $36M initiative for medical AI testing, supporting SMEs and startups in real-world healthcare applications.

Tag: treatment

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Stage 3 lung cancer patients over 70 can receive “active treatment” so “should not give up”

A study shows elderly patients (70+) with stage 3 lung cancer can complete standard treatment, challenging age-related treatment hesitance.

Celltrion’s Steqeyma IV Approval: What This Means for Celltrion’s Growth in Japan’s Autoimmune Drug Market

Celltrion's Steqeyma IV formulation gains approval in Japan, expanding treatment for Crohn's disease and enhancing market competitiveness.

Unlocking Triple Negative Breast Cancer: How Gene-Protein Analysis Predicts Treatment Success

A study reveals that analyzing genetic and protein data can predict chemotherapy effectiveness in triple-negative breast cancer, aiding personalized treatment.

SCL advances digital pathology systems to accelerate precision medicine era

SCL is advancing pathology diagnosis with AI, enhancing accuracy and efficiency in disease detection and personalized treatment.

Daewoong Pharmaceutical Expands Indication for Fexuclue: What This Means for 2026

Daewoong Pharmaceutical submits Phase 3 trial plan for Fexuclue to treat gastric ulcers, aiming to enhance treatment options and patient quality of life.

Allergic Rhinitis Often Mistaken for Common Cold, Risk of Becoming Chronic if Untreated

Allergic rhinitis cases are rising with warmer weather; symptoms include sneezing and congestion. Treatment involves avoidance and medication.

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

Alpha Tau Medical’s Alpha DaRT: A New Hope for Pancreatic Cancer Patients – What You Need to Know

Alpha Tau Medical will present clinical results of its DaRT technology for pancreatic cancer at DDW 2026, marking a significant milestone.

New Genetic Link Revealed: Why Autism Spectrum Disorder Affects Males More Than Females

Researchers at DGIST identify a genetic mutation linked to autism, revealing why it's more common in males and potential treatments.

“Lowering Cholesterol Beyond Current Targets Helps Prevent Cardiovascular Disease”

Lowering LDL cholesterol targets to below 55 mg/dL significantly reduces cardiovascular events in high-risk patients, study shows.

Spring’s Hidden Danger: How Seasonal Changes Can Worsen Depression

Spring can heighten depression risk, requiring awareness and support for those affected. Early intervention is crucial.

Can You Stop Beta-Blockers After a Heart Attack? New Study Reveals Surprising Results!

A study reveals discontinuing beta-blockers after a heart attack poses no increased risk, challenging long-standing treatment norms.

SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm's epilepsy drug Cenobamate launches in China, marking a key milestone in its global expansion and commercialization strategy.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.